Project Manager
Gill Hall - Accident Compensation Corporation (ACC)
The Expert Advisory Group
Dr John MacVicar (Chair) – New Zealand Association of Musculoskeletal Medicine
Dr John Barnard (from April 2004) – Australian and New Zealand College of Anaesthetists
Patsi Davies – University of Waikato; represents the consumer perspective
Mr Nicholas Finnis – Royal Australasian College of Surgeons (Neurosurgeon)
Dr Felicity Goodyear–Smith – Royal New Zealand College of General Practitioners
Mr Chris Hoffman – New Zealand Orthopaedic Association
Dr David Jansen – general practitioner; represents the Maori perspective
Dr David Jones – Faculty of Pain Medicine, Australian and New Zealand College of Anaesthetists
Dr Robert Large – Royal Australian and New Zealand College of Psychiatrists
Judy Leader - College of Nurses Aotearoa
Dr Marina Sew Hoy – Royal Australasian College of Physicians (Rheumatologist)
Professor Ted Shipton – New Zealand Pain Society
Dr Hugh Spencer (up to April 2004) - Australian and New Zealand College of Anaesthetists
Critical Appraisal Team
Ray Kirk (Director), Sarah Hancock, Ian Hodges, Catriona Mackay, Caroline Maskell - New Zealand Health Technology Assessment (NZHTA) unit
Pam Smartt, Claire Tochel - independent consultants
Siiri Bennett, Amanda Bowens, Gill Hall, Jill Nalder – ACC
Information and Library Team
Helen Brodie, Mai Dwairy, Aimee Hawker, Christine Powell, Flora Wallace – ACC
Ex-Officio Advisors
Ingrid Jaegers, Mary Leighton, Kevin Morris – ACC
Acknowledgements
Professor Henry McQuay, Professor of Pain Relief at the Nuffield Department of Anaesthetics, University of Oxford, provided comment on the clinical guidance
Dr Barrie Tait, Consultant Physician at the Christchurch School of Medicine, New Zealand, provided comment on the clinical guidance
Declaration of Competing Interests
Dr Felicity Goodyear-Smith has received funding from ACC for systematic literature reviews / meta-analyses and also for analysis and publication of ACC data.
Mr Chris Hoffman has received funding to support attendance at a number of orthopaedic workshops nationally and internationally.
Dr David Jansen has received funding from Auckland District Health Board, GlaxoSmithKline, Eli Lilly & Co. and ACC for consultancy work.
Dr David Jones has received a consulting honorarium from Pfizer (Australia).
Dr Robert Large received funding from MundiPharma, through the organisers of the Annual Scientific Meeting of the ANZCA Faculty of Pain Medicine, to speak in Perth in May 2004.
Dr Marina Sew-Hoy has received fees for speaking at a medical meeting funded by Merck, Sharp & Dohme and Pharmacia; and has participated in research trials funded by Allergan, GlaxoSmithKline and Celltech.
Professor Ted Shipton has received funding from Pharmacia for consultancy work.
Some members of the advisory group who are in clinical practice receive payments from ACC for the use of interventional pain management procedures.